Affluent Medical SAS Aktie
| 1,23EUR | -0,04EUR | -2,77% |
WKN DE: A3CRZT / ISIN: FR0013333077
Personal
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 0 | 50 | 59 | 63 | 0 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
Bilanz (in Mio. EUR) - Aktiva
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 8 | 15 | 7 | 6 | 0 |
| Summe Anlagevermögen | 57 | 55 | 53 | 51 | 0 |
| Summe Aktiva | 65 | 70 | 60 | 57 | 0 |
Bilanz (in Mio. EUR) - Passiva
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Summe Fremdkapital | 30 | 27 | 26 | 25 | 0 |
| Summe Eigenkapital | 35 | 44 | 34 | 31 | 0 |
| Summe Passiva | 65 | 70 | 60 | 57 | 0 |
Adresse
| 320, avenue Archimède Les pléiades, 13100 Aix-en-Provence | |
| Internet | http://www.affluentmedical.com |
Management
|
Benjamin Renault
Director-Research & Development |
|
Christophe Giot
Vice President-Clinical Affairs |
|
Claire André
Manager-Quality Assurance |
|
Claire Corot
Director |
|
Céline Buard
Director-Marketing |
|
Dominique Carouge
Director |
|
Ellen Roche
Director |
|
Eric Jague
Regulatory Affairs Director |
|
Federica Azzimonti
Director of Clinical Operations |
|
Francois Laborde
Medical Director |
|
Liane Teplitsky
Director |
|
Luc Parisot
Chief Financial Officer |
|
Michel Therin
Chairman |
|
Olivier Belamy
Director-Industrialization |
|
Olivier Pieron
Chief Operating Officer |
|
Patrick Coulombier
Director |
|
Philippe Pouletty
Director |
|
Soad El Ghazouani
Independent Director |
|
Sébastien Ladet
Chief Executive Officer |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.